Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis

Podobne zapisy

• Future Developments in the Treatment of AL Amyloidosis
  od: Foteini Theodorakakou, i wsp.
  Wydane: (2022-02-01)
• Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management
  od: Despina Fotiou, i wsp.
  Wydane: (2020-08-01)
• Prevalence of MGCS Among Patients With Monoclonal Gammopathies
  od: Foteini Theodorakakou, i wsp.
  Wydane: (2023-06-01)
• Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome
  od: Maria Gavriatopoulou, i wsp.
  Wydane: (2020-06-01)
• Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy
  od: Ioannis Ntanasis-Stathopoulos, i wsp.
  Wydane: (2022-08-01)